Metabolic tumor burden as marker of outcome in advanced EGFR wild-type NSCLC patients treated with erlotinib
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Peter Meldgaard Boe Sandahl Sørensen |
| Publication date | February 8, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |